Research progresses of PET molecular imaging for Parkinson disease complicated with levodopa-induced dyskinesia

VernacularTitle:PET分子成像用于帕金森病伴左旋多巴诱导异动症研究进展
Author: Shuang LI ^{1
,

2} ; Tianbin SONG ; Chang YANG ; Jingjuan WANG ; Chun ZHANG ; Jie LU
Author Information

1. 首都医科大学宣武医院放射与核医学科,北京 100053
2. 湖北医药学院附属襄阳市第一人民医院核医学科,湖北襄阳 441000
Keywords: Parkinson disease; brain; levodopa; positron-emission tomography
From: Chinese Journal of Medical Imaging Technology 2024;40(5):774-778
CountryChina
Language:Chinese
Abstract: Levodopa is the standard therapy for Parkinson disease(PD),however,with the progression of the disease and long-term treatment,levodopa-induced dyskinesia(LID)can occur,greatly reducing the quality of patients'life.PET brain molecular imaging can detect the uptake and distribution of imaging agents at the molecular level in vivo,thereby reflecting the brain function and metabolism of patients with PD complicated with LID,which is helpful for early clinical diagnosis and treatment.The research progresses of PET molecular imaging for PD complicated with LID were reviewed in this article.